ARTV Latest Press Releases

-- October 27, 2026 --

Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK Globe Newswire 7:30 AM

-- October 2, 2026 --

Artiva Biotherapeutics Announces Multiple AlloNK Data Presentations at the American College of Rheumatology (ACR) Convergence 2026 Globe Newswire 9:05 AM

-- October 1, 2026 --

Artiva Biotherapeutics Highlights Updated AlloNK Data in Sjgren Disease Presented at the 17th International Symposium on Sjgren's Disease (ISSjD 2026) Globe Newswire 7:30 AM

-- September 23, 2026 --

Artiva Biotherapeutics Announces Oral Presentation of AlloNK Clinical Data at the 17th International Symposium on Sjgren's Disease Globe Newswire 7:30 AM

-- September 17, 2026 --

Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum Globe Newswire 8:00 AM

-- September 8, 2026 --

Artiva Biotherapeutics Provides Update on Planned AlloNK Data Disclosures and Development Milestones for the Remainder of 2026 Globe Newswire 7:30 AM

-- September 2, 2026 --

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September Globe Newswire 8:30 AM

-- August 6, 2026 --

Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM

-- July 17, 2026 --

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- June 23, 2026 --

Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Globe Newswire 4:05 PM

-- June 8, 2026 --

Artiva Biotherapeutics Highlights AlloNK Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today Globe Newswire 6:30 AM

Market Data Delayed 15 Minutes